For: | Lorenzo-Zúñiga V, Llop E, Suárez C, Álvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014; 20(26): 8709-8716 [PMID: 25024629 DOI: 10.3748/wjg.v20.i26.8709] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8709.htm |
Number | Citing Articles |
1 |
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld, T. Wedel. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 2021; 59(12): 1323 doi: 10.1055/a-1591-4794
|
2 |
Juan José Sebastián Domingo. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017; 40(6): 417 doi: 10.1016/j.gastre.2016.12.001
|
3 |
Angela Ancona, Claudia Petito, Irene Iavarone, Valentina Petito, Linda Galasso, Alessia Leonetti, Laura Turchini, Daniela Belella, Daniele Ferrarrese, Giovanni Addolorato, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri. The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease. Digestive and Liver Disease 2021; 53(3): 298 doi: 10.1016/j.dld.2020.11.026
|
4 |
Lucrezia LATERZA, Marco NAPOLI, Valentina PETITO, Franco SCALDAFERRI, Eleonora GAETANI, Antonio GASBARRINI. Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study. Minerva Medica 2023; 114(2) doi: 10.23736/S0026-4806.21.07015-4
|
5 |
Peiwei Xie, Mei Luo, Xuehong Deng, Jiahui Fan, Lishou Xiong. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 2023; 15(17): 3856 doi: 10.3390/nu15173856
|
6 |
Violeta Lorén, Josep Manyé, Mari C. Fuentes, Eduard Cabré, Isabel Ojanguren, Jordi Espadaler. Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis. Probiotics and Antimicrobial Proteins 2017; 9(1): 71 doi: 10.1007/s12602-016-9239-5
|
7 |
Eleonora Gambaro, Carla Gramaglia, Giulia Baldon, Emilio Chirico, Maria Martelli, Alessia Renolfi, Patrizia Zeppegno. “Gut–brain axis”: Review of the role of the probiotics in anxiety and depressive disorders. Brain and Behavior 2020; 10(10) doi: 10.1002/brb3.1803
|
8 |
Charles C. Herndon, Yen‐Po Wang, Ching‐Liang Lu. Targeting the gut microbiota for the treatment of irritable bowel syndrome. The Kaohsiung Journal of Medical Sciences 2020; 36(3): 160 doi: 10.1002/kjm2.12154
|
9 |
Angelica Varesi, Undine-Sophie Deumer, Sanjana Ananth, Giovanni Ricevuti. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications. Journal of Clinical Medicine 2021; 10(21): 5077 doi: 10.3390/jcm10215077
|
10 |
David Groeger, Eileen F. Murphy, Hern Tze Tina Tan, Ida Søgaard Larsen, Ian O'Neill, Eamonn M. M. Quigley. Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination. Neurogastroenterology & Motility 2023; 35(1) doi: 10.1111/nmo.14477
|
11 |
Y. A. McKenzie, R. K. Bowyer, H. Leach, P. Gulia, J. Horobin, N. A. O'Sullivan, C. Pettitt, L. B. Reeves, L. Seamark, M. Williams, J. Thompson, M. C. E. Lomer. British Dietetic Association systematic review and evidence‐based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 549 doi: 10.1111/jhn.12385
|
12 |
P. Roman, F. Carrillo-Trabalón, N. Sánchez-Labraca, F. Cañadas, A.F. Estévez, D. Cardona. Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Beneficial Microbes 2018; 9(4): 603 doi: 10.3920/BM2017.0125
|
13 |
David J. Gracie, Alexander C. Ford. Symbiotics in irritable bowel syndrome – better than probiotics alone?. Current Opinion in Clinical Nutrition and Metabolic Care 2015; 18(5): 485 doi: 10.1097/MCO.0000000000000199
|
14 |
Shanalee C James, Karl Fraser, Wayne Young, Warren C McNabb, Nicole C Roy. Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome. The Journal of Nutrition 2020; 150(5): 1012 doi: 10.1093/jn/nxz302
|
15 |
A.C. Ouwehand. A review of dose-responses of probiotics in human studies. Beneficial Microbes 2017; 8(2): 143 doi: 10.3920/BM2016.0140
|
16 |
Ashton Harper, Malwina Naghibi, Davinder Garcha. The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. Foods 2018; 7(2): 13 doi: 10.3390/foods7020013
|
17 |
Alan C Logan, Martin A Katzman, Vicent Balanzá-Martínez. Natural environments, ancestral diets, and microbial ecology: is there a modern “paleo-deficit disorder”? Part II. Journal of Physiological Anthropology 2015; 34(1) doi: 10.1186/s40101-014-0040-4
|
18 |
Shahnaz Mohammadi, Maryam Izadi-Mazi, Mahsa Akbarian-F. Anxiety and Quality of Life in patients with Irritable Bowel Syndrome. Journal of Medical Sciences 2015; 15(5): 235 doi: 10.3923/jms.2015.235.240
|
19 |
Seung Yong Shin, Sein Park, Jung Min Moon, Kisung Kim, Jeong Wook Kim, Jongsik Chun, Tae Hee Lee, Chang Hwan Choi. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial. Journal of Neurogastroenterology and Motility 2022; 28(4): 642 doi: 10.5056/jnm21202
|
20 |
L. Laterza, G. Gibiino, F. Scaldaferri, A. Gasbarrini. Benefits of multistrain bacteria formulations for health. Journal of Functional Foods 2018; 47: 531 doi: 10.1016/j.jff.2018.05.051
|
21 |
Daniel J. Reis, Stephen S. Ilardi, Stephanie E. W. Punt, Jane Foster. The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. PLOS ONE 2018; 13(6): e0199041 doi: 10.1371/journal.pone.0199041
|
22 |
Viet Hang Dao, Long Bao Hoang, Thi Oanh Trinh, Thi Thu Trang Tran, Van Long Dao. Psychobiotics for Patients with Chronic Gastrointestinal Disorders Having Anxiety or Depression Symptoms. Journal of Multidisciplinary Healthcare 2021; : 1395 doi: 10.2147/JMDH.S312316
|
23 |
V. B. Grinevich, L. B. Lazebnik, Yu. A. Kravchuk, V. G. Radchenko, E. I. Tkachenko, A. M. Pershko, P. V. Seliverstov, C. P. Salikova, K. V. Zhdanov, K. V. Kozlov, V. V. Makienko, I. V. Potapova, E. S. Ivanyuk, D. V. Egorov, E. I. Sas, M. D. Korzheva, N. M. Kozlova, A. K. Ratnikova, V. A. Ratnikov, S. I. Sitkin, L. Z. Bolieva, C. V. Turkina, D. I. Abdulganieva, T. V. Ermolova, S. A. Kozhevnikova, L. V. Tarasova, R. G. Myazin, N. M. Khomeriki, T. L. Pilat, L. P. Kuzmina, R. A. Khanferyan, V. P. Novikova, A. V. Polunina, A. I. Khavkin. Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines. Experimental and Clinical Gastroenterology 2023; (12): 4 doi: 10.31146/1682-8658-ecg-208-12-4-68
|
24 |
Alexander C. Ford, Lucinda A. Harris, Brian E. Lacy, Eamonn M. M. Quigley, Paul Moayyedi. Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2018; 48(10): 1044 doi: 10.1111/apt.15001
|
25 |
Min Chen, Lu Yuan, Chao-Rong Xie, Xiao-Ying Wang, Si-Jia Feng, Xin-Yu Xiao, Hui Zheng. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000658
|
26 |
Vijaya Kavuri, Pooja Selvan, Ariel Malamud, Nagarathna Raghuram, Senthamil R. Selvan. Remedial yoga module remarkably improves symptoms in irritable bowel syndrome patients: A 12-week randomized controlled trial. European Journal of Integrative Medicine 2015; 7(6): 595 doi: 10.1016/j.eujim.2015.11.001
|
27 |
Takumi Sato, Shinichi Honda, Yuji Tominaga, Yo Miyakoshi, Takahiro Ueda, Jinko Sawashita. A probiotic blend improves defecation, mental health, and productivity in healthy Japanese volunteers under stressful situations. Heliyon 2022; 8(9): e10614 doi: 10.1016/j.heliyon.2022.e10614
|
28 |
Kok‐Ann Gwee, Warren Wei‐Rhen Lee, Khoon Lin Ling, Choon Jin Ooi, Seng Hock Quak, Yock Young Dan, Kewin Tien‐Ho Siah, James Guoxian Huang, Andrew Seng Boon Chua, Ida Normiha Hilmi, Raja Affendi Raja Ali, Christina Ong, Marcellus Simadibrata, Murdani Abdullah, Jose D Sollano, Somchai Leelakusolvong, Sutep Gonlachanvit, Yeong Yeh Lee, Jane D Ricaforte‐Campos, Yee Kian Yin, Kuck‐Meng Chong, Chong Yuen Wong. Consensus and contentious statements on the use of probiotics in clinical practice: A south east Asian gastro‐neuro motility association working team report. Journal of Gastroenterology and Hepatology 2018; 33(10): 1707 doi: 10.1111/jgh.14268
|
29 |
Chunying Tian, Yang Huang, Xiaoxia Wu, Chuhan Xu, Huaien Bu, Hongwu Wang, Jairo Kennup Bastos. The Efficacy and Safety of Mesalamine and Probiotics in Mild‐to‐Moderate Ulcerative Colitis: A Systematic Review and Meta‐Analysis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/6923609
|
30 |
John Richard Thompson. Is irritable bowel syndrome an infectious disease?. World Journal of Gastroenterology 2016; 22(4): 1331-1334 doi: 10.3748/wjg.v22.i4.1331
|
31 |
A. Darb Emamie, M. Rajabpour, R. Ghanavati, P. Asadolahi, S. Farzi, B. Sobouti, A. Darbandi. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009–2020. Journal of Applied Microbiology 2021; 130(6): 1823 doi: 10.1111/jam.14907
|
32 |
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova. Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology 2020; (7): 4 doi: 10.31146/1682-8658-ecg-179-7-4-51
|
33 |
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 2019; 11(2): 293 doi: 10.3390/nu11020293
|
34 |
Zubeen Hathi, Srinivas Mettu, Anshu Priya, Sandya Athukoralalage, Tsz Nok Lam, Namita Roy Choudhury, Naba K. Dutta, Emad M. El-Omar, Lan Gong, Geethaanjali Mohan, Carol Sze Ki Lin. Methodological advances and challenges in probiotic bacteria production: Ongoing strategies and future perspectives. Biochemical Engineering Journal 2021; 176: 108199 doi: 10.1016/j.bej.2021.108199
|
35 |
Yan Zhang, Lixiang Li, Chuanguo Guo, Dan Mu, Bingcheng Feng, Xiuli Zuo, Yanqing Li. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0470-z
|
36 |
Geoffrey A. Preidis, Adam V. Weizman, Purna C. Kashyap, Rebecca L. Morgan. AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology 2020; 159(2): 708 doi: 10.1053/j.gastro.2020.05.060
|
37 |
Alan C. Logan, Felice N. Jacka, Jeffrey M. Craig, Susan L. Prescott. The Microbiome and Mental Health: Looking Back, Moving Forward with Lessons from Allergic Diseases. Clinical Psychopharmacology and Neuroscience 2016; 14(2): 131 doi: 10.9758/cpn.2016.14.2.131
|
38 |
Paul Moayyedi, Christopher N Andrews, Glenda MacQueen, Christina Korownyk, Megan Marsiglio, Lesley Graff, Brent Kvern, Adriana Lazarescu, Louis Liu, William G Paterson, Sacha Sidani, Stephen Vanner. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Journal of the Canadian Association of Gastroenterology 2019; 2(1): 6 doi: 10.1093/jcag/gwy071
|
39 |
Beibei Yang, Jinbao Wei, Peijun Ju, Jinghong Chen. Effects of regulating intestinal microbiota on anxiety symptoms: A systematic review. General Psychiatry 2019; 32(2): e100056 doi: 10.1136/gpsych-2019-100056
|
40 |
Muharrem Bayrak. Metabolic syndrome, depression, and fibromyalgia syndrome prevalence in patients with irritable bowel syndrome. Medicine 2020; 99(23): e20577 doi: 10.1097/MD.0000000000020577
|
41 |
Susan L. Prescott, Rachel A. Millstein, Martin A. Katzman, Alan C. Logan. Biodiversity, the Human Microbiome and Mental Health: Moving toward a New Clinical Ecology for the 21st Century?. International Journal of Biodiversity 2016; 2016: 1 doi: 10.1155/2016/2718275
|
42 |
Sarah Lennon, Thomas Lackie, Adriana Miltko, Zoey C. Kearns, Maxime R. Paquette, Richard J. Bloomer, Anyou Wang, Marie van der Merwe. Safety and efficacy of a probiotic cocktail containing P. acidilactici and L. plantarum for gastrointestinal discomfort in endurance runners: randomized double-blinded crossover clinical trial. Applied Physiology, Nutrition, and Metabolism 2024; 49(7): 890 doi: 10.1139/apnm-2023-0449
|
43 |
Nazlı Nur Aslan Çİn, Murat Açik, Oktay Faysal Tertemİz, Çile Aktan, Didem Tuba Akçali, Funda Pınar Çakiroğlu, Ayşe Özfer Özçelİk. Effect of prebiotic and probiotic supplementation on reduced pain in patients with fibromyalgia syndrome: a double-blind, placebo-controlled randomized clinical trial. Psychology, Health & Medicine 2024; 29(3): 528 doi: 10.1080/13548506.2023.2216464
|
44 |
Justus Franz Toader, Andreas Erhardt. Wie wirksam sind Probiotika bei Reizdarm, CED und C.-difficile-Infektionen?. Gastro-News 2023; 10(3): 40 doi: 10.1007/s15036-023-3240-0
|
45 |
Ziran Zhao, Gui Xiao, Jieqiong Xia, Honghua Guo, Xiaoli Yang, Qian Jiang, Hu Wang, Jiaji Hu, Caihong Zhang. Effectiveness of probiotic/prebiotic/synbiotic treatments on anxiety: A systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders 2023; 343: 9 doi: 10.1016/j.jad.2023.09.018
|
46 |
Y. M. Wang, X. Z. Ge, W. Q. Wang, T. Wang, H. L. Cao, B. L. Wang, B. M. Wang. Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues. Neurogastroenterology & Motility 2015; 27(9): 1239 doi: 10.1111/nmo.12615
|
47 |
Bangshan Liu, Yunan He, Mi Wang, Jin Liu, Yumeng Ju, Yan Zhang, Tiebang Liu, Lingjiang Li, Qi Li. Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials. Depression and Anxiety 2018; 35(10): 935 doi: 10.1002/da.22811
|
48 |
V. T. Ivashkin, I. V. Mayev, D. I. Abdulganieva, S. A. Alekseenko, N. Yu. Ivashkina, N. V. Korochanskaya, S. N. Mammaev, E. A. Poluektova, A. S. Trukhmanov, Yu. P. Uspensky, V. V. Tsukanov, O. S. Shifrin, O. Yu. Zolnikova, K. V. Ivashkin, T. L. Lapina, R. V. Maslennikov, A. I. Ulyanin. Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 76 doi: 10.22416/1382-4376-2020-30-2-76-89
|
49 |
Ana D. Cano-Contreras, Isidro J. Minero Alfaro, Víctor M. Medina López, Mercedes Amieva Balmori, José M. Remes Troche, Jordi Espadaler Mazo, Nuria Perez Lopez. Efficacy of i3.1 Probiotic on Improvement of Lactose Intolerance Symptoms. Journal of Clinical Gastroenterology 2022; 56(2): 141 doi: 10.1097/MCG.0000000000001456
|
50 |
Agnieszka Chlebicz-Wójcik, Katarzyna Śliżewska. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Biomolecules 2021; 11(8): 1154 doi: 10.3390/biom11081154
|
51 |
Suk Pyo Shin, Yoon Mi Choi, Won Hee Kim, Sung Pyo Hong, Jong-Min Park, Joohee Kim, Oran Kwon, Eun Hyun Lee, Ki Baik Hahm. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-<i>Lactobacillus gasseri</i> BNR17 mitigated diarrhea-dominant irritable bowel syndrome. Journal of Clinical Biochemistry and Nutrition 2018; 62(2): 179 doi: 10.3164/jcbn.17-73
|
52 |
V. O. Kaibysheva, E. L. Nikonov. Probiotics from the standpoint of evidence-based medicine. Dokazatel'naya gastroenterologiya 2019; 8(3): 45 doi: 10.17116/dokgastro2019803145
|
53 |
Tanima Jana, Brent W. Acker, Brooks D. Cash. Clinical and Basic Neurogastroenterology and Motility. 2020; : 587 doi: 10.1016/B978-0-12-813037-7.00042-X
|
54 |
Maria Rosa Machado Prado, Christian Boller. Discovery and Development of Anti-Inflammatory Agents from Natural Products. 2019; : 259 doi: 10.1016/B978-0-12-816992-6.00009-7
|
55 |
Piero Portincasa, Giuseppe Celano, Nadia Serale, Paola Vitellio, Francesco Maria Calabrese, Alexandra Chira, Liliana David, Dan L. Dumitrascu, Maria De Angelis. Clinical and Metabolomic Effects of Lactiplantibacillus plantarum and Pediococcus acidilactici in Fructose Intolerant Patients. Nutrients 2022; 14(12): 2488 doi: 10.3390/nu14122488
|
56 |
Soubhagya Tripathy, Ami R. Patel, Deepak Kumar Verma, Smita Singh, Gemilang Lara Utama, Mamta Thakur, Alaa Kareem Niamah, Nihir Shah, Shayma Thyab Gddoa Al‐Sahlany, Prem Prakash Srivastav, Mónica L. Chávez‐González, Cristobal Noe Aguilar. Microbial Bioreactors for Industrial Molecules. 2023; : 443 doi: 10.1002/9781119874096.ch21
|
57 |
K. Preston, R. Krumian, J. Hattner, D. de Montigny, M. Stewart, S. Gaddam. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Beneficial Microbes 2018; 9(5): 697 doi: 10.3920/BM2017.0105
|
58 |
Angela Horvath, Bettina Leber, Nicole Feldbacher, Norbert Tripolt, Florian Rainer, Andreas Blesl, Markus Trieb, Gunther Marsche, Harald Sourij, Vanessa Stadlbauer. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. European Journal of Nutrition 2020; 59(7): 2969 doi: 10.1007/s00394-019-02135-w
|
59 |
L. B. Lazebnik, E. V. Golovanova, B. A. Volel, N. V. Korochanskaya, E. A. Lyalyukova, M. V. Mokshina, S. N. Mekhtiev, O. A. Mekhtieva, Z. V. Metsaeva, D. S. Petelin, V. I. Simanenkov, S. I. Sitkin, S. V. Cheremushkin, M. V. Chernogorova, А. I. Khavkin. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology 2021; (8): 5 doi: 10.31146/1682-8658-ecg-192-8-5-117
|
60 |
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, E. A. Belousova, P. A. Makarchuk, E. Yu. Eremina, A. S. Sarsenbaeva, D. I. Abdulganieva, L. V. Tarasova, O. A. Gromova, V. A. Ratnikov, K. V. Kozlov, A. K. Ratnikova. Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). Experimental and Clinical Gastroenterology 2021; (3): 5 doi: 10.31146/1682-8658-ecg-187-3-5-82
|
61 |
Alan C Logan. Dysbiotic drift: mental health, environmental grey space, and microbiota. Journal of Physiological Anthropology 2015; 34(1) doi: 10.1186/s40101-015-0061-7
|
62 |
Charlotte Le Morvan de Sequeira, Marie Kaeber, Sila Elif Cekin, Paul Enck, Isabelle Mack. The Effect of Probiotics on Quality of Life, Depression and Anxiety in Patients with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(16): 3497 doi: 10.3390/jcm10163497
|
63 |
Pauline JOUËT, Claude ALTMAN, Stanislas BRULEY DES VARANNES, Christine JUHEL, Franck HENRI. Probiotics plus vitamin D in irritable bowel syndrome: a prospective multicentric non-interventional study. Minerva Gastroenterology 2024; 70(3) doi: 10.23736/S2724-5985.24.03581-2
|
64 |
Sevda Eskandarzadeh, Mohammad Effatpanah, Kianoush Khosravi-Darani, Reza Askari, Agha Fatemeh Hosseini, Mahnaz Reisian, Shima Jazayeri. Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial. Nutritional Neuroscience 2021; 24(2): 102 doi: 10.1080/1028415X.2019.1598669
|
65 |
Alexander C. Ford, Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito, Eamonn M. M. Quigley. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 2018; 113: 1 doi: 10.1038/s41395-018-0084-x
|
66 |
Atieh Darbandi, Arezoo Asadi, Roya Ghanavati, Roghayeh Afifirad, Amir Darb Emamie, Maryam kakanj, Malihe Talebi. The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20. International Journal of Infectious Diseases 2021; 105: 91 doi: 10.1016/j.ijid.2021.02.011
|
67 |
S. I. Sitkin, T. M. Pervunina. Chronic pancreatitis and the intestinal microbiome in adults and children: Not only SIBO but also gut dysbiosis has clinical significance. Experimental and Clinical Gastroenterology 2022; (12): 125 doi: 10.31146/1682-8658-ecg-196-12-125-133
|
68 |
Y. A. McKenzie, J. Thompson, P. Gulia, M. C. E. Lomer. British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 576 doi: 10.1111/jhn.12386
|
69 |
V. T. Ivashkin, I. V. Maev, D. I. Abdulganieva, S. A. Alekseenko, A. V. Gorelov, I. N. Zakharova, O. Yu. Zolnikova, N. Yu. Ivashkina, N. V. Korochanskaya, S. N. Mammayev, E. A. Poluektova, A. S. Trukhmanov, D. V. Usenko, Yu. P. Uspensky, V. V. Tsukanov, O. S. Shifrin, I. V. Berezhnaya, K. V. Ivashkin, T. L. Lapina, R. V. Maslennikov, S. V. Nikolaeva, N. G. Sugyan, A. I. Ulyanin. Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(2): 65 doi: 10.22416/1382-4376-2021-31-2-65-91
|
70 |
Jamie M. Joseph, Catrin Law. Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes. Neuroscience & Biobehavioral Reviews 2019; 99: 160 doi: 10.1016/j.neubiorev.2018.11.010
|
71 |
Richard T. Liu, Rachel F.L. Walsh, Ana E. Sheehan. Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews 2019; 102: 13 doi: 10.1016/j.neubiorev.2019.03.023
|
72 |
Jalal Moludi, Amir Saber, Morteza Arab Zozani, Shima Moradi, Yasaman Azamian, Salimeh Hajiahmadi, Yahya Pasdar, Fardin Moradi. The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies. Preventive Nutrition and Food Science 2024; 29(3): 237 doi: 10.3746/pnf.2024.29.3.237
|
73 |
Indira Benjak Horvat, Ivana Gobin, Andrea Kresović, Goran Hauser. How can probiotic improve irritable bowel syndrome symptoms?. World Journal of Gastrointestinal Surgery 2021; 13(9): 923-940 doi: 10.4240/wjgs.v13.i9.923
|
74 |
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
|
75 |
Advances in Probiotics for Sustainable Food and Medicine. Microorganisms for Sustainability 2021; 21: 181 doi: 10.1007/978-981-15-6795-7_8
|
76 |
Youhe Wu, Yuetong Li, Qi Zheng, Lanjuan Li. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 2024; 16(13): 2114 doi: 10.3390/nu16132114
|
77 |
Thamires M. S. Milani, Camila M. Sandy, Ana Paula Carvalho Thiers Calazans, Rosana Q. Silva, Vanessa M. B. Fonseca, Flaviano S. Martins, Marcos C. Borges. Dose–Response Effect of Saccharomyces cerevisiae UFMG A-905 on the Prevention of Asthma in an Animal Model. Probiotics and Antimicrobial Proteins 2024; 16(1): 53 doi: 10.1007/s12602-022-10014-w
|
78 |
Bing Li, Li Liang, Huijie Deng, Jinmin Guo, He Shu, Li Zhang. Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00332
|
79 |
Carolina Marques Lopes, Cristina Sofia de Jesus Monteiro, Ana Paula Duarte, Jorge Luiz dos Santos. Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review. Journal of Clinical Medicine 2024; 13(21): 6337 doi: 10.3390/jcm13216337
|
80 |
O.R. Denesyuk , O.Yu. Gubska. THE MOST COMMON DISORDERS OF THE INTESTINE-BRAIN AXIS IN PATIENTS WITH GLUTEN-DEPENDENT DISEASES ON THE BACKGROUND OF MEDICAL NUTRITION AND THE POSSIBILITY OF THEIR CORRECTION. Medical Science of Ukraine (MSU) 2024; 20(1): 67 doi: 10.32345/2664-4738.1.2024.09
|
81 |
Nazar Mazurak, Ellen Broelz, Martin Storr, Paul Enck. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?. Journal of Neurogastroenterology and Motility 2015; 21(4): 471 doi: 10.5056/jnm15071
|
82 |
Weida Wang, Haiwei Xin, Xiucai Fang, Hongtao Dou, Fangyi Liu, Dan Huang, Shaomei Han, Guijun Fei, Liming Zhu, Shenghua Zha, Hong Zhang, Meiyun Ke, David D. Roberts. Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats. PLOS ONE 2017; 12(4): e0175276 doi: 10.1371/journal.pone.0175276
|
83 |
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 2016; 22(7): 2219-2241 doi: 10.3748/wjg.v22.i7.2219
|
84 |
L. Thayumanavan, M. Tarakeswari, K. Muthukumaran. Probiotics in Gastroenterology. Gastroenterology, Hepatology and Endoscopy Practice 2021; 1(1): 11 doi: 10.4103/ghep.ghep_13_20
|
85 |
Juan José Sebastián Domingo. Revisión del papel de los probióticos en la patología gastrointestinal del adulto. Gastroenterología y Hepatología 2017; 40(6): 417 doi: 10.1016/j.gastrohep.2016.12.003
|
86 |
Chao-Rong Xie, Bin Tang, Yun-Zhou Shi, Wen-Yan Peng, Kun Ye, Qing-Feng Tao, Shu-Guang Yu, Hui Zheng, Min Chen. Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.853011
|
87 |
Francisco Guarner, Mary Ellen Sanders, Hania Szajewska, Henry Cohen, Rami Eliakim, Claudia Herrera-deGuise, Tarkan Karakan, Dan Merenstein, Alejandro Piscoya, Balakrishnan Ramakrishna, Seppo Salminen, Jim Melberg. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. Journal of Clinical Gastroenterology 2024; 58(6): 533 doi: 10.1097/MCG.0000000000002002
|
88 |
Spiros Paramithiotis, Eleftherios H. Drosinos. Innovations in Technologies for Fermented Food and Beverage Industries. 2018; : 143 doi: 10.1007/978-3-319-74820-7_8
|
89 |
Ding Liang, Ning Longgui, Xu Guoqiang. Efficacy of different probiotic protocols in irritable bowel syndrome. Medicine 2019; 98(27): e16068 doi: 10.1097/MD.0000000000016068
|
90 |
Daniela Mailänder-Sánchez, Christina Braunsdorf, Christian Grumaz, Christoph Müller, Stefan Lorenz, Philip Stevens, Jeanette Wagener, Betty Hebecker, Bernhard Hube, Franz Bracher, Kai Sohn, Martin Schaller, Julian R. Naglik. Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion. PLOS ONE 2017; 12(10): e0184438 doi: 10.1371/journal.pone.0184438
|
91 |
Damini Kothari, Seema Patel, Soo-Ki Kim. Probiotic supplements might not be universally-effective and safe: A review. Biomedicine & Pharmacotherapy 2019; 111: 537 doi: 10.1016/j.biopha.2018.12.104
|
92 |
Sahar Foshati, Masoumeh Akhlaghi, Siavash Babajafari. The effect of pro-/synbiotic supplementation on the brain-derived neurotrophic factor: a systematic review and meta-analysis of randomized controlled trials. Food & Function 2022; 13(17): 8754 doi: 10.1039/D2FO01330D
|
93 |
A.M. van der Geest, I. Besseling-van der Vaart, E.M. Schellinger-de Goede, M.B. van der Waal, E. Claassen, J. Flach, L.H.M. van de Burgwal. Multispecies probiotics promote perceived human health and wellbeing: insights into the value of retrospective studies on user experiences. Beneficial Microbes 2021; 12(5): 413 doi: 10.3920/BM2020.0162
|
94 |
A. P. S. Hungin, C. R. Mitchell, P. Whorwell, C. Mulligan, O. Cole, L. Agréus, P. Fracasso, C. Lionis, J. Mendive, J.‐M. Philippart de Foy, B. Seifert, K.‐A. Wensaas, C. Winchester, N. de Wit. Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1054 doi: 10.1111/apt.14539
|
95 |
Anura Manandhar, Ghadeer Sabir, Hala A Abdelhady, Adoum Oumar Abakar, Ravindra Reddy Gangavarapu, Sayed A Mahmud, Iana Malasevskaia. Probiotic Potential in Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Comprehensive Systematic Review. Cureus 2024; doi: 10.7759/cureus.72089
|
96 |
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1): e89 doi: 10.1097/MRM.0000000000000284
|